Adverse reactions to watch for in patients using herbal remedies

Western Journal of Medicine

Volumn 171, Issue 3, 1999, Pages 181-186

  Ko, Richard ^a  

^a MS 357 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INTERACTION; HUMAN; MEDICINAL PLANT; PHYTOTHERAPY;

DRUG INTERACTIONS; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 0033195396     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998;280:1569-1575.
2. Johnston BA. One-third of nation's adults use herbal remedies. Herbalgram 1997;40:49.
3. O'Hara MA, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998;7:523-536.
4. Spaulding-Albright N. A review of some herbal and related products commonly used in cancer patients. J Am Diet Assoc 1997 Oct;97(10 Suppl 2):S208-S215.
5. D'Arcy PF. Adverse reactions and interactions with herbal medicines: part 1, adverse reactions. Adverse Drug React Toxicol Rev 1991;10(4):189-208.
6. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998 Nov 9;158(20):2200-2211.
7. The review of natural products: facts and comparisons. St. Louis (MO): Lippincott, 1998.
8. Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999 Mar 1;59(5):1239-1245.
9. D'Arcy PF. Adverse reactions and interactions with herbal medicines: part 2, drug interactions. Adverse Drug React Toxicol Rev 1993;12(3):147-162.
10. De Smet PAGM. Health risks of herbal remedies. Drug Safety 1995;13:81-93.
11. Blumenthal M, Busse WR, Goldberg A, et al. The complete German Commission E monographs: therapeutic guide to herbal medicines. Austin (TX): American Botanical Council; 1998.
12. Shaw D, Leon C Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991-1995). Drug Safety 1997 Nov;17(5):342-356.
13. Fackelmann K. Medicine for menopause. Science News 1998 June 20;153:392-393.
14. But PPH, Tai YT, Young K. Three fatal cases of herbal aconite poisoning. Vet Hum Toxicol 1994;36(3):212-215.
15. Gordon DW, Rosenthal G, Hart J, et al. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995;273:489-490.
16. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129-132.
17. Picciotto A, Campo N, Brizzolara R, et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998 Jan;28(1):165-167.
18. Horowitz RS, Feldhaus K, Dart RC, et al. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996;156(8):899-903.
19. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 1996;91:1436-1438.
20. Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995;40:1845-1848.
21. Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997;92(4):703-704.
22. Bah M, Bye R, Pereda-Miranda R. Hepatotoxic pyrrolizidine alkaloids in the Mexican medicinal plant Packera candidissima (Asteraceae: Senecioneac). J Ethnopharmacol 1994;43(1):19-30.
23. Roulet M, Laurini R, Rivier L, Calame A. Hepatic veno-ocdusive disease in newborn infant of a woman drinking herbal tea. J Pediatrics 1988;112:433-436.
24. McLean EK. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol Rev 1970;22:429-482.
25. Larrey D. Liver involvement in the course of phytotherapy [editorial; in French]. Presse Med 1994;23(15):691-693.
26. Izumotani T, Ishimura E, Tsumura K, et al. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs. Nephron 1993;65(1):137-140.
27. Abt AB, Oh JY, Huntington RA, Burkhart KK. Chinese herbal medicine induced acute renal failure. Arch Intern Med 1995;155:211-212.
28. Adverse events associated with ephedrine-containing products - Texas, December 1993-September 1995. MMWR Morb Mortal Wkly Rep 1996 Aug 16;45(32):689-693.
29. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998 Sep 17;339(12):847.
30. Zink T, Chaffin J. Herbal health products: what family physicians need to know. Am Fam Physician 1998 Oct 1;58(5):1133-1140.
31. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997 July 1;127:61-69.
32. Chen HC, Hsieh MT, Chang SS, Liu SL. Long-term renocardiovascular effects of orally administered Aconiti tuber in humans. Am J Chin Med 1990;1-2:25-33.
33. Kao WF, Hung DZ, Tsai WJ, et al. Podophyllotoxin intoxication: toxic effect of bajiaolian in herbal therapeutics. Hum Exp Toxicol 1992;11:480-487.
34. Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998 Nov 11;280(18):1604-1609.
35. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997 Oct 22-29;278(16):1327-1332.
36. Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression -an overview and meta-analysis of randomised clinical trials. BMJ 1996 Aug 3;313(7052):253-258.
37. Mouren X, Gaillard P, Schwartz F. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination. Angiology 1994 Jun;45(6):413-417.
38. Ivaniv OP. The results of using different forms of a Ginkgo biloba extract (Egb 761) in the combined treatment of patients with circulatory encephalopathy. Lik Sprava 1998 Dec;(8):123-128.
39. Smith PF, Darlington CL. Can vestibular compensation be enhanced by drug treatment? A review of recent evidence. J Vestib Res 1994 May-Jun;4(3):169-179.
40. Holgers KM, Axelsson A, Pringle I. Ginkgo biloba extract for the treatment of tinnitus. Audiology 1994 Mar-Apr;33(2):85-92.
41. Moyad MA, Hathaway S, Ni HS. Traditional Chinese medicine, acupuncture, and other alternative medicines for prostate cancer an introduction and the need for more research. Semin Urol Oncol 1999 May;17(2):103-110.
42. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998 Apr-Jun;24(2):139-143.
43. Hruby K, Csomos G, Fuhrmann M, Thaler H. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol 1983 Apr;2(2):183-195.
44. Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver: a double-blind controlled study. Scand J Gastroenterol 1982 Jun;17(4):517-521.
45. Aikins Murphy P. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol 1998 Jan;91(1):149-155.
46. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992 Feb;36(1):27-38.
47. Zee-Cheng RK. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT: a potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find Exp Clin Pharmacol 1992 Nov;14(9):725-736.
48. Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999 Feb;106(2):138-143.
49. Brinkebom RM, Shah DV, Degenring FH. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold: a randomized, placebo-controlled, double-blind clinical trial. Phytomedicine 1999 Mar;6(1):1-6.
50. Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Altern Complement Med 1995 Summer;1(2):145-160.
51. Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998 Feb 16;168(4):170-171.
52. Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis 1989 Jul;48(7):547-549.
53. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia 1998 Dec;18(10):704-703.
54. Makheja AN, Bailey JM. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Prostaglandins Leukot Med 1982 Jun;8(6):653-660.
55. Hausen BM. A 6-year experience with compositae mix. Am J Contact Dermat 1996 Jun;7(2):94-99.
56. Pugh WJ, Sambo K. Prostaglandin synthetase inhibitors in feverfew. J Pharm Pharmacol 1988 Oct;40(10):743-745.
57. McCrindle BW, Hdden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998 Nov;152(11):1089-1094.
58. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 1998 Oct;27(3):232-235.
59. Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998 Jun 17;279(23):1900-1902.
60. Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998 Jun 8;158(11):1189-1194.
61. Steiner M, Lin RS. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol 1998 Jun;31(6):904-908.
62. Kiesewetter H, Jung F, Jung EM, et al. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol 1993;45(4):333-336.
63. Jappe U, Bonnekoh B, Hausen BM, Gollnick H. Garlic-related dermatoses: case report and review of the literature. Am J Contact Dermat 1999 Mar;10(1):37-39.
64. Schmid R, Schick T, Steffen R, et al. Comparison of seven commonly used agents for prophylaxis of seasickness. J Travel Med 1994 Dec 1;1(4):203-206.
65. Visalyaputra S, Petchpaisit N, Somcharoen K, Choavaratana R. The efficacy of ginger root in the prevention of postoperative nausea and vomiting after outpatient gynaecological laparoscopy. Anaesthesia 1998 May;53(5):506-510.
66. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger) - an antiemetic for day case surgery. Anaesthesia 1993 Aug;48(8):715-717.
67. Janssen PL, Meyboom S, van Staveren WA, et al. Consumption of ginger (Zingiber officinale roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996 Nov;50(11):772-774.
68. Verma SK, Singh J, Khamesra R, Bordia A. Effect of ginger on platelet aggregation in man. Indian J Med Res 1993 Oct;98:240-242.
69. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992 Dec;39(4):342-348.
70. Kanerva L, Estlander T, Jolanki R. Occupational allergic contact dermatitis from spices. Contact Dermatitis 1996 Sep;35(3):157-162.
71. Oken BS; Storzbach DM; Kaye JA The efficacy of Ginkgo biloba on cognitive function Alzheimer disease. Arch Neurol 1998 Nov;55(11):1409-1415.
72. Li MH, Zhang HL, Yang BY. Effects of ginkgo leave concentrated oral liquor in treating asthma. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 1997 Apr;17(4):216-218.
73. Luo HC, Shen YC, Meng FQ. Therapeutic effect of shuxuening combining neuroleptics for the treatment of chronic schizophrenia - a double blind study. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 1997 Mar;17(3):139-142.
74. Fleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992 Oct;34(4):352-358.
75. Pietri S, Seguin JR, d'Arbigny P, et al. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 1997 Apr;11(2):121-131.
76. Emerit I, Arutyunyan R, Oganesian N, et al. Radiation-induced clastogenic factors: anticlastogenic effect of Ginkgo biloba extract. Free Radic Biol Med 1995 Jun;18(6):985-991.
77. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993 Jul-Sep;88(7-9):447-457.
78. Steinke B, Muller B, Wagner H. Biological standardization of Ginkgo extracts. Planta Med 1993 Apr;59(2):155-160.
79. Vale S. Subarachnoid hemorrhage associated with Ginkgo biloba. Lancet 1998 Jul 4;352(9121):36.
80. White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996;58(16):1315-1321.
81. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108.
82. Caso Marasco A, Vargas Ruiz R, Salas Villagomez A, Begona Infante C. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996;22(6):323-329.
83. D'Angelo L, Grimaldi R, Caravaggi M, et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol 1986 Apr-May;16(1):15-22.
84. Allen JD, McLung J, Nelson AG, Welsch M. Ginseng supplementation does not enhance healthy young adults' peak aerobic exercise performance. J Am Coll Nutr 1998 Oct;17(5):462-466.
85. Engels HJ, Wirth JC. No ergogenic effects of ginseng (Panax ginseng C.A. Meyer) during graded maximal aerobic exercise. J Am Diet Assoc 1997 Oct;97(10):1110-1115.
86. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22(2):65-72.
87. Scaglione F, Ferrara F, Dugnani S, et al. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 1990; 16(10):537-542.
88. Yun TK, Choi SY. Non-organ-specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998 Jun;27(3):359-364.
89. Koren G, Randor S, Martin S, Danneman D. Maternal ginseng use associated with neonatal androgenization. JAMA 1990 Dec 12;264(22):2866.
90. Jones BD, Runikis AM. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987 Jun;7(3):201-202.
91. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Aft Med J 1997 May;74(5):283-284.
92. Rabbani GH, Butler T, Knight J, et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 1987 May;155(5):979-984.
93. Khin-Maung-U, Myo-Khin, Nyunt-Nyunt-Wai, et al. Clinical trial of berberine in acute watery diarrhoea. Br Med J (Clin Res Ed) 1985 Dec 7;291(6509):1601-1605.
94. Huang W. Ventricular tachyarrhythmias treated with berberine. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 1990 Jun;18(3):155-156,190.
95. Ho NK. Traditional Chinese medicine and treatment of neonatal jaundice. Singapore Med J 1996 Dec;37(6):645-651.
96. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate 1993;63(4):201-208.
97. Gerber GS, Zagaja GP, Bales GT, et al. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998 Jun;51(6):1003-1007.
98. Plosker GL, Brogden RN. Serenoa repens (Permixon): a review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 1996 Nov;9(5):379-395.
99. Josey ES, Tackett RL. St. John's wort: a new alternative for depression? Int J Clin Pharmacol Ther 1999 Mar;37(3):111-119.
100. Miller AL. St. John's wort (Hypericum perforatum): clinical effects on depression and other conditions. Altern Med Rev 1998 Feb;3(1):18-26.
101. Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 1998 Oct;54(8):589-594.
102. Brockmoller J, Reum T, Bauer S, et al. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 1997 Sep;30 Suppl 2:94-101.
103. Ondrizek RR, Chan PJ, Patton WC, King A. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet 1999 Feb;16(2):87-91.
104. Simmen U, Schweitzer C, Burkard W, Schaffner W. Hypericum perforatum inhibits the binding of mu- and kappa-opioid receptor expressed with the Semliki Forest virus system. Pharm Acta Helv 1998 Jun;73(1):53-56.
105. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology (Berl) 1985;87(4):406-409.
106. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav 1989 Apr;32(4):1065-1066.
107. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998 Nov 11;280(18):1566-1567.